BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31352641)

  • 1. MAGI1 mediates tumor metastasis through c-Myb/miR-520h/MAGI1 signaling pathway in renal cell carcinoma.
    Wang W; Yang Y; Chen X; Shao S; Hu S; Zhang T
    Apoptosis; 2019 Dec; 24(11-12):837-848. PubMed ID: 31352641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression.
    Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y
    Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.
    Dey N; Das F; Ghosh-Choudhury N; Mandal CC; Parekh DJ; Block K; Kasinath BS; Abboud HE; Choudhury GG
    PLoS One; 2012; 7(6):e37366. PubMed ID: 22685542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells.
    Sun M; Guo S; Yao J; Xiao Y; Sun R; Ma W; Dong Z
    J Cell Biochem; 2019 Feb; 120(2):1894-1902. PubMed ID: 30187954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
    Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
    Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-205-5p-Mediated MAGI1 Inhibition Attenuates the Injury Induced by Diabetic Nephropathy.
    Xiang Y; Sun M; Wu Y; Hu Y
    Pharmacology; 2024; 109(2):98-109. PubMed ID: 38325349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
    Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
    J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-486-5p-directed MAGI1/Rap1/RASSF5 signaling pathway contributes to hydroquinone-induced inhibition of erythroid differentiation in K562 cells.
    Ma X; Zhang X; Luo J; Liang B; Peng J; Chen C; Guo H; Wang Q; Xing X; Deng Q; Huang H; Liao Q; Chen W; Hu Q; Yu D; Xiao Y
    Toxicol In Vitro; 2020 Aug; 66():104830. PubMed ID: 32198055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.
    Zaman MS; Thamminana S; Shahryari V; Chiyomaru T; Deng G; Saini S; Majid S; Fukuhara S; Chang I; Arora S; Hirata H; Ueno K; Singh K; Tanaka Y; Dahiya R
    PLoS One; 2012; 7(11):e50203. PubMed ID: 23189187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
    Liu F; Chen N; Xiao R; Wang W; Pan Z
    Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation.
    Zhao T; Liang X; Chen J; Bao Y; Wang A; Gan X; Lu X; Wang L
    Biochem Biophys Res Commun; 2019 Aug; 516(3):880-887. PubMed ID: 31270029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
    Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
    Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
    Peng H; Wang X; Zhang P; Sun T; Ren X; Xia Z
    Int J Clin Exp Pathol; 2015; 8(2):2259-66. PubMed ID: 25973137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
    Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
    Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
    Wang X; Jiang F; Song H; Li X; Xian J; Gu X
    Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
    Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.